• print
  • mail
  • Home
  • Media
  • In the News
  • Amgen at ASCO 2010

  • Overview
  • Fact Sheets
  • Featured Content
  • Press Releases
  • Social Media
  • Media Contacts
  • In the News
  • Virtual Press Kits
In the News

Amgen at ASCO 2010

Results from studies involving nine molecules in Amgen’s oncology portfolio will be presented at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago June 4-8, 2010.

Abstracts are available on the ASCO website at http://abstract.asco.org/ and updated data will be presented at the meeting.

If you’re at ASCO, stop by Amgen’s booth 7063 to see Amgen’s angiogenesis research come to life in 3D and to learn more about our oncology pipeline.

Follow Amgen on Twitter at http://twitter.com/amgen to receive news updates during ASCO, or check this page for updates.

May. 20, 2010
Amgen Highlights Key Clinical Data to Be Presented at American Society of Clinical Oncology Annual Meeting
Jun. 4, 2010
New AMG 479 Phase 2 Data Show Antitumor Activity in Patients With Metastatic Pancreatic Cancer
Jun. 5, 2010
New Analyses of Denosumab Pivotal Phase 3 Trials Reinforce Potential Advantages Over Standard of Care
Jun. 5, 2010
Denosumab Demonstrated Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Prostate Cancer
Jun. 5, 2010
Striking the Balance: Community Experts Come Together for High-Level Dialogue on Cancer Care
Jun. 6, 2010
New AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer
 

 


  • Related Links
  • Follow us on Twitter
  • Angiogenesis.Amgen.com
footer